Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(9 sites)
United States
EyePoint Investigational Site, Huntington Beach, California EyePoint Investigational Site, Palo Alto, California EyePoint Investigative Site, Boston, Massachusetts EyePoint Investigational Site, Jackson, Mississippi EyePoint Investigational Site, Omaha, Nebraska EyePoint Investigational Site, Buffalo, New York EyePoint Investigative Site, New York, New York EyePoint Investigational Site, Rochester, New York EyePoint Investigational Site, Charleston, South Carolina